V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001828 | 230004301 | 1.68 | 90 | null | 2020-11-21 | 2020-12-16 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100446663 |
| 230001829 | 230004302 | null | null | null | 2018-12-15 | 2019-09-06 | null | null | null | RUCAPARIB | 100408458 |
| 230001830 | 230004303 | 1.59 | 65 | Palliative (P) | 2016-11-18 | 2019-03-29 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101640860 |
| 230001831 | 230004304 | null | 59.9 | Adjuvant (A) | null | 2019-11-09 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100302475 |
| 230001833 | 230004306 | 0 | 50 | null | 2016-01-27 | 2016-02-12 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100136319 |
| 230001834 | 230004307 | null | null | null | null | 2019-07-10 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100996111 |
| 230001835 | 230004308 | 1.65 | 54.9 | null | 2019-05-27 | 2019-06-03 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101058651 |
| 230001836 | 230004309 | 1.68 | 108.6 | Curative (C) | 2017-12-03 | 2018-11-21 | null | null | N | LIPOSOMAL DOXORUBICIN | 101573628 |
| 230001837 | 230004310 | 1.56 | 50.6 | null | null | 2018-04-26 | null | null | null | CARBOPLATIN | 100220621 |
| 230001838 | 230004311 | null | null | Palliative (P) | null | 2020-04-30 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100117641 |
| 230001841 | 230004314 | null | null | null | 2017-02-23 | 2017-03-16 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101359449 |
| 230001843 | 230004316 | 1.59 | 86.4 | Palliative (P) | null | 2019-10-30 | Bevacizumab | 02 | N | BEVACIZUMAB | 100828002 |
| 230001844 | 230004317 | 1.55 | 78.3 | null | 2019-04-22 | 2019-04-30 | Niraparib | 02 | null | NIRAPARIB | 101500385 |
| 230001846 | 230004319 | null | null | Palliative (P) | 2018-12-18 | 2019-01-08 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100249299 |
| 230001847 | 230004320 | 1.66 | 96 | Adjuvant (A) | 2018-06-17 | 2020-04-26 | null | null | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101281306 |
| 230001849 | 230004322 | 1.47 | 86.2 | Palliative (P) | 2018-04-15 | 2018-04-21 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100280148 |
| 230001852 | 230004325 | 1.57 | 76 | Palliative (P) | 2019-03-01 | 2019-07-09 | IPILIMUMAB + NIVOLUMAB | 02 | N | CISPLATIN + DOXORUBICIN | 100373086 |
| 230001854 | 230004326 | null | null | null | null | 2016-12-19 | null | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101816803 |
| 230001856 | 230004328 | 1.52 | 82.2 | null | null | 2017-01-01 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101237930 |
| 230001857 | 230004329 | null | 101 | null | 2017-01-02 | 2017-01-02 | null | null | null | OLAPARIB | 100311486 |
| 230001859 | 230004331 | null | null | null | 2019-05-01 | 2019-05-01 | null | null | null | NIRAPARIB | 101692331 |
| 230001860 | 230004332 | null | null | Adjuvant (A) | null | 2019-12-03 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100210848 |
| 230001863 | 230004334 | 1.54 | 96.2 | Palliative (P) | 2019-09-17 | 2019-10-10 | Olaparib | 02 | N | OLAPARIB | 101006637 |
| 230001866 | 230004337 | 1.75 | 54.1 | null | 2019-11-10 | 2019-12-23 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100122229 |
| 230001870 | 230004341 | 1.61 | 119 | Palliative (P) | null | 2019-09-24 | DOXORUBICIN | null | null | CARBOPLATIN | 101857326 |
| 230001872 | 230004342 | 1.59 | 104.8 | Palliative (P) | 2020-03-04 | 2020-03-18 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100015099 |
| 230001873 | 230004343 | 1.6 | 68.6 | null | 2020-02-10 | 2020-03-06 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101552669 |
| 230001874 | 230004344 | 1.72 | 80.5 | null | 2020-10-10 | 2020-10-18 | null | null | null | CARBOPLATIN + GEMCITABINE | 101123322 |
| 230001876 | 230004346 | 1.55 | 57.8 | null | 2020-06-16 | 2020-06-22 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101241810 |
| 230001877 | 230004347 | null | null | null | 2019-03-23 | 2019-05-06 | PACLITAXEL | 02 | null | PACLITAXEL | 100775316 |
| 230001879 | 230004349 | null | null | Palliative (P) | 2021-07-05 | 2021-07-24 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101577356 |
| 230001880 | 230004350 | 1.57 | 72.8 | null | null | 2020-09-19 | null | null | null | DOXORUBICIN | 101351228 |
| 230001881 | 230004351 | null | null | null | 2015-10-30 | 2016-02-15 | null | 01 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100660284 |
| 230001882 | 230004352 | null | null | null | null | 2018-02-21 | Bevacizumab | 02 | null | BEVACIZUMAB | 101329981 |
| 230001884 | 230004354 | 1.5 | 82 | Palliative (P) | 2019-12-28 | 2019-12-28 | NIVOLUMAB | null | Y | CARBOPLATIN + GEMCITABINE | 101428540 |
| 230001887 | 230004356 | 1.67 | 49.5 | null | 2018-04-26 | 2018-04-28 | IPILIMUMAB + NIVOLUMAB | 02 | null | DOXORUBICIN | 101026562 |
| 230001888 | 230004357 | null | null | Adjuvant (A) | null | 2018-09-05 | Carboplatin + Liposomal Doxorubicin | 02 | Y | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101164031 |
| 230001889 | 230004358 | 1.66 | 76.3 | Palliative (P) | null | 2019-04-12 | null | N | N | RUCAPARIB | 100343419 |
| 230001890 | 230004359 | null | null | null | null | 2019-05-29 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101429851 |
| 230001891 | 230004360 | 1.58 | 77.2 | null | 2016-08-17 | 2016-08-18 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100321720 |
| 230001892 | 230004361 | null | null | null | 2019-01-11 | 2019-01-27 | Niraparib | 02 | null | NIRAPARIB | 100977905 |
| 230001895 | 230004364 | 1.68 | 0 | Curative (C) | null | 2020-01-12 | null | 02 | Y | IPILIMUMAB + NIVOLUMAB | 100799567 |
| 230001896 | 230004365 | 1.53 | 96 | null | 2019-10-10 | 2019-10-30 | null | null | null | LIPOSOMAL DOXORUBICIN | 100671866 |
| 230001897 | 230004366 | null | null | null | 2020-05-05 | 2020-10-28 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101635198 |
| 230001902 | 230004371 | null | null | Palliative (P) | 2020-07-06 | 2020-07-23 | Niraparib | 02 | N | NIRAPARIB | 101810384 |
| 230001905 | 230004374 | 1.63 | 46.5 | null | 2022-03-11 | 2022-03-17 | ICON8B TRIAL | 02 | null | TRIAL UNSPECIFIED | 100855772 |
| 230001906 | 230004375 | 1.57 | 81 | null | null | 2016-09-27 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100657504 |
| 230001908 | 230004377 | null | null | null | 2019-11-05 | 2019-11-12 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101180570 |
| 230001909 | 230004378 | null | null | Adjuvant (A) | 2017-07-26 | 2017-08-23 | Cisplatin + Radiotherapy | N | N | PEMBROLIZUMAB | 100692521 |
| 230001911 | 230004380 | null | null | null | null | 2017-02-11 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100037088 |